A similar reduction in MGMT labeling by O6PGG/azido-PEG-FITC upon pre-treating cells with O6BG was observed with four additional primary GBM cell lines (GBM111, GBM115, GBM133, and GBM175) and is shown in Supplementary Figure S2. This evidence concerns the gene MGMT and glioblastoma.